2m Koreans opt out of life
Nearly two million individuals in Korea have formally declined life-extending medical interventions, choosing instead to prioritize their right to die with dignity when suffering from a terminal condition, data showed Sunday.
Data from the National Agency for Management of Life-Sustaining Treatment reveals that as of the end of August, 1,941,231 people have filed an advance health care directive to abstain from life-saving medical assistance since the system's inception in February 2018.
Women make up the majority of individuals opting for this choice, accounting for 68 percent, or 1,319,812, of those registered, with men accounting for the remaining 32 percent, or 621,419.
Less than 100,000 people registered for the health care directive in 2018. However, the number surged to 530,000 in 2019, 790,000 in 2020, 1,160,000 in 2021 and 1,570,000 in 2022.
Judging from the current monthly growth rate, the number is projected to exceed two million in October.
Five and half years have passed since the so-called "Death with Dignity Act" came into effect in Korea in February 2018. The act enabled people to refuse life-prolonging medical treatment.
Any adult over the age of 19 can register for the advance medical directive detailing treatment plans in the case of terminal illness, which they can also withdraw from at any time.
The necessary documents can be submitted to the National Agency for Management of Life-Sustaining Treatment, and the information will then be registered in a government database shared by hospitals and public health institutions. Life-sustaining treatment can be halted under several conditions if an individual falls terminally ill. The requirements include confirmation by a family member, approval from the ethics committee at a medical institution, and the agreement of the patient’s primary doctor and another doctor who is an expert in the field.
Currently, four types of treatment -- cardiopulmonary resuscitation, use of artificial respiration, hemodialysis and administration of anti-cancer drugs -- are categorized as life-extension care by the government.
(责任编辑:직업)
- “러시아 공군기, 평양 도착…북러 간 접촉 활발”
- Kakao completes its first own data center
- '코로나 봉쇄' 북한, 국경 열었다…3년8개월 만에 외국인 입국
- Broadcom to appeal S. Korean regulator's fine over unfair Samsung Electronics deal
- “러시아 공군기, 평양 도착…북러 간 접촉 활발”
- Seoul shares tumble to 5
- [Herald Interview] Kim Jee
- Major Korean firms fare worse than US counterparts in H1
- 120,000 more public homes to be supplied by this year
- Benois de la Danse winner Kang Mi
- 카메라 찍힌 김여정 960만원 '디올 백'…그 자체가 北인권 참상
- [Herald Interview] Song Joong
- [Herald Interview] S&P economist tells Korea to brace for worst
- [Herald Interview] Mimiirose hopes to make a name for itself
- BTS agency likely to face tougher disclosure rules
- NK slams Yoon's warning against Pyongyang
- Political strife may delay Korea’s launch of new space agency
- KB chief hopes successor transforms group into 'Samsung of finance'
- [Herald Interview] Forever is not impossible: Oneus aspires to global reach with 'La Dolce Vita'
- Govt. to survey spending on private education of preschoolers, Suneung retakers
- Hospital visits during Chuseok cost up to 50% more views+
- Biz outlook stays flat for October amid slowing economy views+
- NewJeans sings 2023 Lol World Championship anthem views+
- Young swimmer enjoys self views+
- Hyundai Steel to showcase low views+
- Intangible cultural heritage exhibitions, performances head overseas views+
- N. Korean envoy vows stronger 'self views+
- Do professors in Korea have too much power over students? views+
- Trilateral talks open on Korea views+
- Nam June Paik Art Center to be led by new director Park Nam views+